Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $2,886,555 were purchased by Sabag Mark on Feb 12 ’25. At $16.25 per share, Sabag Mark acquired 177,626 shares.
Also, MIGNONE ROBERTO sold 286,000 shares, netting a total of over 6,294,031 in proceeds. Following the sale of shares at $22.01 each, the insider now holds 695,000 shares.
Before that, Bridger Management, LLC (1) had added 286,000 shares to its account. In a trade valued at $6,094,660, the Shareholder bought Teva- Pharmaceutical Industries Ltd. ADR shares for $21.31 each.
As published in a research note from Argus on July 10, 2024, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] has been rated up from a Hold to a Buy and the price target has been revised to $20. Analysts at JP Morgan upgraded the stock from ‘”an Underweight”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of February 12, 2024, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for TEVA. Earlier on January 23, 2024, Jefferies upgraded its rating. Their new recommendation was “a Buy” for TEVA stock which previously was a “a Hold”.
Analyzing TEVA Stock Performance
During the last five days, there has been a drop of approximately -3.82%. Over the course of the year, Teva- Pharmaceutical Industries Ltd. ADR shares have dropped approximately -24.55%. Shares of the company reached a 52-week high of $22.40 on 01/28/25 and a 52-week low of $16.13 on 02/12/25. A 50-day SMA is recorded $19.61, while a 200-day SMA reached $17.78. Nevertheless, trading volume fell to 11.07 million shares from 12.96 million shares the previous day.
Support And Resistance Levels for Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
According to the 24-hour chart, there is a support level at 16.40, which, if violated, would cause prices to drop to 16.18. In the upper region, resistance lies at 16.80. The next price resistance is at 16.97. RSI (Relative Strength Index) is 28.78 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.30, which suggests the price will decrease in the coming days. Percent R is at 92.03%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
